Douglas Tsao's
Stock Forecasts

Douglas Tsao win rate

0%

0/19 win trades

Douglas Tsao is a Wall Street stock analyst with a 0% win rate, who was right in predicting 0 out of 19 price targets. Most frequently covered stocks by this analyst are ARGX, APLS, PTGX and SAGE. He has published 0 price targets in the last month and 5 last year.

Price targets by Douglas Tsao

Company name & ticker Publish date Price target Price when posted Source Historical targets
APLS logo
Apellis Pharmaceuticals, Inc.
APLS
 11 months ago $57 114.12% upside $27.01 StreetInsider
SAGE logo
Sage Therapeutics, Inc.
SAGE
 11 months ago $14 61.10% upside $8.48 TheFly Previous targets (0)
DARE logo
Daré Bioscience, Inc.
DARE
 11 months ago $12 482.52% upside $3.5 StreetInsider Previous targets (0)
ALKS logo
Alkermes plc
ALKS
 12 months ago $37 27.58% upside $28.91 StreetInsider Previous targets (0)
XENE logo
Xenon Pharmaceuticals Inc.
XENE
 12 months ago $53 41.86% upside $39.37 TheFly Previous targets (0)
BHVN logo
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
 about 1 year ago $59 280.89% upside $45.94 StreetInsider Previous targets (0)
IRON logo
Disc Medicine, Inc.
IRON
 about 1 year ago $70 20.31% upside $47.79 StreetInsider Previous targets (0)
PTGX logo
Protagonist Therapeutics, Inc.
PTGX
 about 1 year ago $50 -11.03% downside $45.08 StreetInsider
TBPH logo
Theravance Biopharma, Inc.
TBPH
 about 1 year ago $15 11.52% upside $9.59 TheFly Previous targets (0)
ARGX logo
argenx SE
ARGX
 about 1 year ago $533 -18.86% downside $492.07 StreetInsider
RVNC logo
Revance Therapeutics, Inc.
RVNC
 over 1 year ago $11 201.36% upside $4.29 TheFly Previous targets (0)
VRDN logo
Viridian Therapeutics, Inc.
VRDN
 over 1 year ago $27 51.60% upside $14.9 StreetInsider Previous targets (0)
NERV logo
Minerva Neurosciences, Inc.
NERV
 over 1 year ago $7 204.34% upside $2.4 StreetInsider Previous targets (0)
EVO logo
Evotec SE
EVO
 over 1 year ago $11 202.19% upside $5.23 StreetInsider Previous targets (0)
ROIV logo
Roivant Sciences Ltd.
ROIV
 over 1 year ago $18 51.26% upside $10.92 StreetInsider Previous targets (0)

Other analysts covering same stocks

Daan Vandenberk
Kepler Capital
100%
win rate
Covering:
Tiago Fauth
Credit Suisse
85.71%
win rate
Covering:
AMGNAPLSBMRNFMTXRXDXUTHR …
Gary Nachman
BMO Capital
66.67%
win rate
Covering:
Laura Chico
Wedbush
57.14%
win rate
Covering:
APLSARDXBIIBLRMRNBIXPHVS …
Laura Sutcliffe
UBS
50%
win rate
Covering:
Marc Goodman
Leerink Partners
50%
win rate
Covering:
Srikripa Devarakonda
Truist Financial
40%
win rate
Covering:
Alethia Young
Cantor Fitzgerald
33.33%
win rate
Covering:
ALNYAPLSASNDBIIBGBTICPT …
Yatin Suneja
Guggenheim
33.33%
win rate
Covering:
ACADANABARGXAXSMBIIBIMVT …
Salveen Richter
Goldman Sachs
32%
win rate
Covering:
ALNYAMGNBIIBBLUEBPMCDNLI …
Tazeen Ahmad
Bank of America Securities
30.77%
win rate
Covering:
ACADALNYARGXARVNASNDBNTX …
Vamil Divan
Mizuho Securities
28.57%
win rate
Covering:
Derek Archila
Wells Fargo
26.92%
win rate
Covering:
ANNXAPLSARGXARVNBPMCCCCC …
Akash Tewari
Jefferies
26.92%
win rate
Covering:
ALKSAPLSARGXBNTXCYTKEXEL …
Corinne Jenkins
Goldman Sachs
25%
win rate
Covering:
ALECFULCGERNHALOHRMYIDYA …
David Risinger
Leerink Partners
23.08%
win rate
Covering:
ABBVANABBMYGILDHLVXLLY …
Sumant Kulkarni
Canaccord Genuity
22.22%
win rate
Covering:
ANVSBIIBCARACLNNCRVOITCI …
Paul Matteis
Stifel Nicolaus
22.22%
win rate
Covering:
ACADALKSALNYBIIBBMRNCTNM …
Allison Bratzel
Piper Sandler
20%
win rate
Covering:
Gregory Renza
RBC Capital
20%
win rate
Covering:
AGIOAMGNCATXCRMDFULCIDYA …
Evan David Seigerman
BMO Capital
17.65%
win rate
Covering:
ABBVAMGNBIIBBMYGILDINCY …